Q32 Bio Inc. Proceeds from Sale and Maturity of Marketable Securities
Q32 Bio Inc. (FIXX) reported Proceeds from Sale and Maturity of Marketable Securities of $56.88 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2023-05-11
- Q32 Bio Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2023-03-31 was $56.88M.
- Q32 Bio Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2022-03-31 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month |
|---|---|
| 2023-03-31 | $56.88M 10-Q · filed 2023-05-11 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |